Four Thought Financial Partners, LLC Astrazeneca PLC Transaction History
Four Thought Financial Partners, LLC
- $1.14 Trillion
- Q3 2025
A detailed history of Four Thought Financial Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Four Thought Financial Partners, LLC holds 147,010 shares of AZN stock, worth $13.1 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
147,010
Previous 143,455
2.48%
Holding current value
$13.1 Million
Previous $10 Billion
12.51%
% of portfolio
0.99%
Previous 0.99%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...